
1. infect immun. 2015 jun;83(6):2453-65. doi: 10.1128/iai.02474-14. epub 2015 mar
30.

in vitro anti-plasmodium falciparum properties full set human secreted 
phospholipases a2.

guillaume c(1), payré c(2), jemel i(2), jeammet l(2), bezzine s(2), naika gs(3), 
bollinger j(3), grellier p(1), gelb mh(3), schrével j(1), lambeau g(4),
deregnaucourt c(5).

author information: 
(1)muséum national d'histoire naturelle, umr 7245 cnrs/mnhn, mcam équipe bamee,
paris, france.
(2)institut de pharmacologie moléculaire et cellulaire, cnrs et université de
nice sophia antipolis, umr 7275, sophia antipolis, valbonne, france.
(3)departments chemistry biochemistry, university washington, seattle, 
washington, usa.
(4)institut de pharmacologie moléculaire et cellulaire, cnrs et université de
nice sophia antipolis, umr 7275, sophia antipolis, valbonne, france
deregnau@mnhn.fr lambeau@ipmc.cnrs.fr.
(5)muséum national d'histoire naturelle, umr 7245 cnrs/mnhn, mcam équipe bamee,
paris, france deregnau@mnhn.fr lambeau@ipmc.cnrs.fr.

we previously shown secreted phospholipases a2 (spla2s) animal
venoms inhibit vitro development plasmodium falciparum, agent of
malaria. addition, inflammatory-type human group iia (hgiia) spla2
circulates high levels serum malaria patients. however, role 
the different human spla2s host defense p. falciparum been
investigated. show 4 10 human spla2s, namely, hgx, hgiif,
hgiii, hgv, exhibit potent vitro anti-plasmodium properties with
half-maximal inhibitory concentrations (ic50s) 2.9 ± 2.4, 10.7 ± 2.1, 16.5 ±
9.7, 94.2 ± 41.9 nm, respectively. human spla2s, including hgiia, are
inactive. inhibition dependent spla2 catalytic activity primarily
due hydrolysis plasma lipoproteins parasite culture. accordingly, 
purified lipoproteins prehydrolyzed hgx, hgiif, hgiii, hgv 
are toxic p. falciparum native lipoproteins. however, total
enzymatic activities human spla2s purified lipoproteins plasma not
reflect inhibitory activities p. falciparum. instance, hgiif is
9-fold toxic hgv releases lower quantity nonesterified fatty
acids (nefas). lipidomic analyses released nefas lipoproteins demonstrate
that spla2s anti-plasmodium properties release
polyunsaturated fatty acids (pufas), hgiif selective enzyme. 
nefas purified lipoproteins hydrolyzed hgiif potent at
inhibiting p. falciparum hgv, pufa-enriched liposomes
hydrolyzed spla2s highly toxic, demonstrating critical role pufas.
the selectivity spla2s toward low- high-density (ldl hdl,
respectively) lipoproteins ability directly attack parasitized
erythrocytes explain anti-plasmodium activity. together, our
findings indicate 4 human spla2s active p. falciparum vitro
and pave way future investigations vivo contribution in
malaria pathophysiology.

copyright © 2015, american society microbiology. rights reserved.

doi: 10.1128/iai.02474-14 
pmcid: pmc4432757
pmid: 25824843  [indexed medline]

